How to Reconstitute KLOW Blend (Lab Mixing Guide + Math)

Reconstituting the KLOW blend requires careful volumetric math and aseptic technique. PX1 Research supplies high-purity research peptides verified by third-party HPLC/MS and endotoxin testing per lot. Synthesized in the USA, our 80 mg KLOW blend vials ship same-day (M–F) from CA and AZ, accompanied by full lot-specific analytical certificates for reliable laboratory experimentation.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Reconstituting the KLOW blend requires careful volumetric math and aseptic technique. PX1 Research supplies high-purity research peptides verified by third-party HPLC/MS and endotoxin testing per lot. Synthesized in the USA, our 80 mg KLOW blend vials ship same-day (M–F) from CA and AZ, accompanied by full lot-specific analytical certificates for reliable laboratory experimentation.

Reviewed by PX1 Research scientific team

Key takeaways

  • Reconstituting a multi-peptide mixture like the klow blend demands strict adherence to analytical chemistry standards to protect molecular integrity.
  • The klow peptide combination is a specialized research formulation designed for in vitro and animal model investigation into cellular repair, tissue remodeling, and inflammatory signaling pathways.
  • Before beginning the reconstitution protocol, ensure your laboratory work area is prepped inside a verified laminar flow hood or a sanitized biosafety cabinet.
  • Step 1: Sanitize the workspace thoroughly with 70% isopropyl alcohol.

At a glance: Laboratory guidelines for KLOW blend reconstitution

Reconstituting a multi-peptide mixture like the klow blend demands strict adherence to analytical chemistry standards to protect molecular integrity. Researchers must calculate fluid volume precise to the milligram of active lyophilized cake, ensuring target working concentrations are met without compromising peptide solubility.

Always utilize sterile bacteriostatic water (0.9% benzyl alcohol) as the primary reconstituting diluent for multi-use laboratory assays. Introduce the liquid slowly against the internal glass wall of the vial under ambient pressure control. Never direct the fluid stream straight into the lyophilized cake.

Avoid shaking or mechanically agitating the solution. Gently swirl the vial in a circular motion until the lyophilized powder dissolves completely into a clear liquid. Store reconstituted samples at 2°C to 8°C in a temperature-monitored laboratory refrigerator away from UV light exposure.

What is the KLOW peptide blend in research?

The klow peptide combination is a specialized research formulation designed for in vitro and animal model investigation into cellular repair, tissue remodeling, and inflammatory signaling pathways. It combines four distinct research peptides into a single standardized lyophilized matrix: BPC-157, TB-500 (Thymosin Beta-4 fragment), GHK-Cu (Copper Tripeptide-1), and KPV (Lysine-Proline-Valine).

In preclinical studies, these individual active agents demonstrate synergistic characteristics. BPC-157 and TB-500 are heavily studied for angiogenic and musculoskeletal structural support, GHK-Cu for extracellular matrix gene modulation, and KPV for downregulating pro-inflammatory cytokine pathways. You can review the analytical specifications for our high-purity 80 mg KLOW blend vial directly on our product catalog.

Because this complex multi-component formulation contains diverse molecular weights and hydrophobic profiles, proper reconstitution is crucial to maintain uniform distribution across each aliquot without causing peptide aggregation or premature cleavage.

What lab equipment is required before reconstituting?

Before beginning the reconstitution protocol, ensure your laboratory work area is prepped inside a verified laminar flow hood or a sanitized biosafety cabinet. Having all necessary reagents and volumetric tools laid out prevents contamination risks and analytical variance.

Required lab equipment includes: a sterile vial of 80 mg KLOW blend, bacteriostatic water containing 0.9% benzyl alcohol, 70% isopropyl alcohol prep pads, sterile 3 mL diluent syringes with 21G–25G needles, and low retention polypropylene microcentrifuge tubes or storage vials.

Ensure that all diluents and target vials are allowed to equilibrate to ambient room temperature (20°C to 22°C) prior to fluid addition. Introducing cold diluent to room-temperature lyophilized powder can create thermal shock, potentially disrupting delicate tertiary structures in larger peptides like TB-500.

How to mix KLOW blend: Step-by-step laboratory protocol

Step 1: Sanitize the workspace thoroughly with 70% isopropyl alcohol. Pop the plastic protective flip-top caps off both the klow blend vial and the bacteriostatic water vial. Thoroughly swab the rubber stoppers with an alcohol pad and allow them to air-dry completely for 30 seconds.

Step 2: Unsheathe a sterile 3 mL reconstitution syringe. Draw air equal to the desired volume of diluent (e.g., 2.0 mL or 3.0 mL) into the barrel, insert the needle into the bacteriostatic water vial, equalize pressure, and invert to draw the exact volume of liquid needed.

Step 3: Carefully insert the syringe needle into the rubber stopper of the klow peptide vial at a 45-degree angle against the inner glass wall. Because lyophilized vials are vacuum-sealed, the plunger may pull forward naturally; control the plunger velocity to allow the diluent to trickle slowly down the glass wall rather than blasting the powder directly.

Step 4: Once the fluid is fully introduced, equalize internal pressure by withdrawing an equivalent volume of air from the headspace into the empty syringe before pulling the needle out of the rubber stopper.

Step 5: Hold the vial between your thumb and index finger and gently swirl in smooth, circular motions. Never shake, vortex, or violently agitate the solution, as shear forces can break peptide bonds or cause cloudiness and protein precipitation. Allow the vial to sit resting on the bench for 5–10 minutes until the solution turns perfectly clear.

Reconstitution concentration math and worked examples

Understanding how to calculate working concentrations is fundamental when designing controlled laboratory assays. The fundamental formula for calculating solution concentration ($C$) is total mass of peptide ($m$) divided by total reconstituted liquid volume ($V$):

Concentration (mg/mL) = Mass of Total Peptide (mg) / Reconstitution Diluent Volume (mL)

For an 80 mg total peptide mass vial (such as the PX1 Research KLOW formulation containing proportional concentrations of BPC-157, TB-500, GHK-Cu, and KPV), the math scales based on how much bacteriostatic water is added to the vial:

Example A: Adding 2.0 mL BAC water to an 80 mg vial yields a final total peptide concentration of 40 mg/mL (80 mg / 2.0 mL = 40 mg/mL). In this preparation, every 0.1 mL (10 units on a standard 100-unit U-100 volumetric laboratory syringe) contains 4.0 mg of total peptide matrix.

Example B: Adding 4.0 mL BAC water to an 80 mg vial yields a final total peptide concentration of 20 mg/mL (80 mg / 4.0 mL = 20 mg/mL). In this preparation, every 0.1 mL contains 2.0 mg of total peptide matrix.

Example C: Adding 8.0 mL BAC water (transferred to a secondary sterile container if vial volumetric headspace permits) yields a concentration of 10 mg/mL (80 mg / 8.0 mL = 10 mg/mL), meaning 0.1 mL contains 1.0 mg of total complex.

How to store and preserve reconstituted KLOW peptide solutions

Lyophilized research peptides remain highly stable at -20°C for up to 24 months when stored dry and away from light. However, once reconstituted with bacteriostatic water, hydrolysis and enzymatic oxidation begin to slowly degrade the compounds over time.

Store all reconstituted liquid vials in a dedicated laboratory refrigerator held strictly between 2°C and 8°C (36°F to 46°F). Ensure the vial is protected from direct ambient room lighting by placing it inside its original box or an opaque storage rack.

Do not freeze reconstituted solutions containing bacteriostatic water. Repeated freeze-thaw cycles fracture the peptide bonds and destabilize the antimicrobial preservative (benzyl alcohol), causing precipitation and accelerated loss of structural integrity. Liquid samples stored at 2–8°C should generally be utilized within 30 to 45 days in research settings.

How to vet a peptide supplier for laboratory research

Sourcing accurate compounds is critical to ensuring baseline reproducibility across in vitro assays and preclinical models. When evaluating vendor options, compare them against strict analytical benchmarks rather than marketing hype:

1. Purity Verification: Every batch must feature accessible, lot-specific High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis confirming >99.0% purity.

2. Endotoxin Data: Vendors must provide quantitative bacterial endotoxin testing (LAL assay) confirming levels below 0.05 EU/mg to eliminate confounding immune responses in biological models.

3. Sourcing Integrity: Choose suppliers utilizing USA synthesis protocols and rigid quality assurance frameworks rather than unverified re-sellers.

4. Lot Traceability: Vials must display matching lot numbers that link directly to verifiable raw analytical spectra published publicly on the vendor site.

5. Shipping Speed: Rapid order fulfillment from domestic facilities prevents exposure of delicate lyophilized compounds to excessive transit temperatures.

6. Technical Support: Access to responsive scientific support that understands lab logistics, volumetric reconstitution, and compound stability.

Red flags when purchasing research peptide blends

The research chemical landscape contains varying levels of vendor oversight. Researchers should remain cautious of suppliers that fail to meet baseline chemical verification standards.

Avoid vendors offering multi-component blends without listing exact milligram breakdown ratios for each constituent peptide (e.g., BPC-157, TB-500, GHK-Cu, KPV). Blends without standardized component ratios introduce uncontrollable variables into controlled research environments.

Be wary of suppliers providing generic, recycled, or blurred Certificates of Analysis (COAs) that lack verifiable batch numbers or third-party laboratory verification seals. Always confirm that the COA matches the exact lot printed on the product packaging.

Refuse to buy from suppliers making explicit human consumption, dosing, or therapeutic administration claims. Legitimate vendor operations like PX1 Research cater exclusively to academic institutions, private biotechnology laboratories, and qualified independent researchers.

Ordering from PX1 Research

When your laboratory requires uncompromising quality and immediate fulfillment, PX1 Research delivers. Every lot of our BPC-157 / TB-500 / GHK-Cu / KPV KLOW Blend 80mg is synthesized to >99% purity and rigorously batch-verified through independent HPLC/MS and endotoxin testing.

Orders placed before our daily cutoff time ship same-day (Monday through Friday) from our climate-controlled distribution hubs in California and Arizona. Vials are packaged in heavy-duty, light-blocking security materials to ensure transit protection. Bulk volume pricing for higher-throughput screening programs is available via our wholesale peptide program.

Explore our complete catalog of specialized compounds across our primary peptide collection or review full technical documentation in our centralized research library. Select your required research compounds today to receive lot-matched, analytical-grade materials delivered directly to your laboratory bench.

Frequently Asked Questions

What diluent should be used to mix KLOW blend?

Bacteriostatic water (0.9% benzyl alcohol) is the standard diluent for reconstituting the KLOW blend. The benzyl alcohol inhibits bacterial growth, allowing the reconstituted solution to remain stable in laboratory refrigeration (2°C–8°C) for multi-use research protocols over 30 to 45 days.

How much bacteriostatic water do I add to an 80 mg KLOW vial?

The amount of water depends on your target concentration. Adding 2.0 mL of BAC water to an 80 mg vial yields a total peptide concentration of 40 mg/mL. Adding 4.0 mL yields 20 mg/mL. Calculate your assay requirements prior to mixing.

Why shouldn't I shake the vial when reconstituting?

Shaking introduces mechanical shear forces that can disrupt secondary and tertiary protein structures, causing peptides like TB-500 or GHK-Cu to denature or aggregate. Always swirl gently in a circular motion to dissolve powder safely.

How long does reconstituted KLOW blend remain stable?

When reconstituted with bacteriostatic water and preserved at 2°C–8°C in a temperature-monitored laboratory refrigerator, liquid KLOW blend remains stable for approximately 30 to 45 days before gradual aqueous degradation occurs.

Do you provide a COA for my specific KLOW blend lot?

Yes. PX1 Research provides batch-specific Certificates of Analysis for every lot. Our COAs detail HPLC purity percentages, Mass Spectrometry structural confirmation, and LAL endotoxin testing results accessible directly on our website.

Can I freeze reconstituted KLOW blend after mixing?

Freezing reconstituted liquid containing bacteriostatic water is not recommended. Freeze-thaw cycles break down peptide chains and cause the benzyl alcohol preservative to separate, destabilizing the solution. Store liquid samples at 2°C–8°C.

How fast does PX1 Research ship KLOW blend orders?

Orders placed before our daily afternoon cutoff ship same-day (Monday through Friday) from our fulfillment centers in California and Arizona. Packages are shipped with tracked domestic transit to ensure rapid laboratory delivery.

Is the KLOW blend suitable for human administration?

No. All products sold by PX1 Research, including the KLOW blend, are strictly manufactured for laboratory research use, in vitro assays, and preclinical animal models. They are never intended for human or clinical use.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.